Effect of oxatomide, an antiallergic agent, on QT interval in dogs

Arzneimittel-Forschung/Drug Research

Volumn 51, Issue 12, 2001, Pages 971-976

  Iwamoto, K I ^a   Ikeda, J I ^a   Nito, M ^a   Kosaka, N ^a   Ichikawa, S ^a   Ohmori, K ^a   Sakai, K I ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

Antiallergic drugs; CAS 50679 08 8; CAS 60607 34 3; CAS 84625 61 6; Itraconazole; KW 4354, dog, effect on QT interval; Oxatomide; Terfenadine

Indexed keywords

ANTIALLERGIC AGENT; ANTIFUNGAL AGENT; ITRACONAZOLE; OXATOMIDE; TERFENADINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DOG; DRUG EFFECT; ELECTROCARDIOGRAM; FEMALE; HEART RATE; HEART VENTRICLE ARRHYTHMIA; LONG QT SYNDROME; MALE; NONHUMAN; PATHOGENESIS; QT INTERVAL;

EID: 0035664812     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300147     Document Type: Article

References (23)

1. Cardiotoxic effect with convulsions in terfenadine overdose
2. Itraconazole affects single-dose terfenadine pharmacokinetics and cardiac repolarization pharmacodynamics
3. Drug-induced torsade de pointes: From molecular biology to bedside
4. Astemizole-induced torsade de pointes
5. Accidental astemizole overdose in young children
6. Oxatomide, a new orally active drug which inhibits both the release and the effects of allergic mediators
7. Inhibitory effects of oxatomide on several activities of SRS-A and synthetic leukotrienes in guinea-pigs and rats
8. Pharmacological studies on oxatomide: (6) Effect on the peripheral organs
9. 1 receptor antagonists on action potentials in guinea-pig isolated papillary muscles
10. Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole
11. Assessment of QTc, prolongation for non-cardiac-related drugs from a drug development perspective
12. Electrophysiologic mechanisms of the long QT interval syndromes and torsade de pointes
13. An analysis of the time-relations of electrocardiograms
14. Rate-corrected QT interval: Techniques and limitations
15. Pharmacokinetics and biotransformation studies of terfenadine in man
16. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects
17. Torsades de pointes occurring in association with terfenadine use
18. Oxidation of the antihistaminic drug terfenadine in human liver microsomes. Role of cytochrome P-450 3A(4) in N-dealkylation and C-hydroxylation
19. Itraconazole prevents terfenadine metabolism and increases risk of torsades de pointes ventricular tachycardia
20. Cardiotoxic and drug interaction profile of the second generation antihistamines ebastine and terfenadine in an experimental animal model of torsade de pointes
21. Plasma levels, biotransformation and excretion of oxatomide (R 35 443) in rats, dogs and man
22. Oxatomide plasma levels in man during chronic dosing